Serum interferon-gamma (IFN-γ) in chronic oral candidosis

References

• Luna MA, Tortoledo ME. Histologic identification and pathologic patterns of disease caused by Candida. Candidiasis: Pathogenesis, Diagnosis, and Treatment2nd edn., GP Bodey. Raven Press, New York 1993; 21–42, In
   Google Scholar
• Odds FC. Candida infections: an overview. Crit Rev Microbiol 1987; 15: 1–5
   PubMed Web of Science ®Google Scholar
• Ghannoum MA, Abu-Elteen KH. Pathogenicity determinants of Candida. Mycoses 1990; 33: 265–282
   PubMed Web of Science ®Google Scholar
• Romani, L, Mencacci, A, Cenci, E, et al. Course of primary candidiasis in T cell-depleted mice infected with attenuated variant cells. J Infect Dis 1992; 166: 1384–1392
   PubMed Web of Science ®Google Scholar
• Romani, L, Mencacci, A, Grohmann, U, et al. Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J Exp Med 1992; 176: 19–25
   PubMed Web of Science ®Google Scholar
• Cassone A, DeBernardis F, Mondello F, Ceddia T, Agatensi L. Evidence for a correlation between proteinase secretion and vulvovaginal candidosis. J Infect Dis 1987; 156: 777–783
   PubMed Web of Science ®Google Scholar
• Staib F. Serum-proteins as nitrogen source for yeastlike fungi. Sabouraudia 1965; 4: 187–193
   PubMedGoogle Scholar
• Szarmach H, Małyszko E, Wroński A, Niczyporuk W. Yeast-like flora of the male and female urogenital system with regard to enzymatic activity and clinical symptoms. Przeg Dermatol 1982; 69: 47–51
   PubMedGoogle Scholar
• Ijzermans JNM, Marquet RL. Interferon g. A review. Immuno-biology 1989; 179: 456–473
   PubMed Web of Science ®Google Scholar
• Romagnani S. Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease. Int J Clin Lab Res 1991; 21: 152–158
   PubMedGoogle Scholar
• Cenci, E, Mencacci, A, Spaccapelo, R, et al. T helper cell type 1 (Th 1)- and Th 2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th 1 development. J Infect Dis 1995; 171: 1279–1288
   PubMed Web of Science ®Google Scholar
• Cenci, E, Romani, L, Mencacci, A, et al. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol 1993; 23: 1034–1038
   PubMed Web of Science ®Google Scholar
• Richardson MD, Smith H. Resistance of virulent and attenuated strains of Candida albicans to intracellular killing by human and mouse phagocytes. J Infect Dis 1981; 144: 557–562
   PubMed Web of Science ®Google Scholar
• Young RC, Bennett JE, Geelhoed GW, Levine AS. Fungemia with compromised host resistance. Ann Intern Med 1974; 80: 605–612
   PubMed Web of Science ®Google Scholar
• Diamond RD, Lyman CA, Wysong DR. Disparate effects of interferon-gamma and tumornecrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro. J Clin Invest 1991; 87: 711–720
   PubMed Web of Science ®Google Scholar
• Vazquez-Torres A, Jones-Carson J, Balish E. Candidacidal activity of macrophages from immunocompetent and congenitally immunodeficient mice. J Infect Dis 1994; 170: 180–188
   PubMed Web of Science ®Google Scholar
• van Kullberg BJ, van'tWout JW, Hoogstraten C, van Furth R. Recombinant interferon-γ enhances resistance to acute disseminated Candida albicans infection in mice. J Infect Dis 1993; 168: 436–443
   PubMed Web of Science ®Google Scholar
• Cantorna MT, Balish E. Role of CD4+ lymphocytes in resistance to mucosal candidiasis. Infect Immun 1991; 59: 2447–2455
   PubMed Web of Science ®Google Scholar
• Romani, L, Mencacci, A, Tonnetti, L, et al. Interleukin-12 but not interferon-gamma production correlates with induction of T helper type-1 phenotype in murine candidiasis. Eur J Immunol 1994; 24: 909–915
   PubMed Web of Science ®Google Scholar
• Bocci V. The physiological interferon response. Immunol Today 1985; 6: 7–9
   PubMedGoogle Scholar
• Katila H, Cantell K, Appelberg B, Rimón R. Is there a seasonal variation in the interferon-producing capacity of healthy subjects?. J Interfer Res 1993; 13: 233–234
   PubMedGoogle Scholar
• Kishida T, Kita M, Yamaji M, Kaneto E, Teramatsu T. Interferon producing capacity in patients with liverdiseases, diabetes mellitus, chronic diseases and malignant diseases. The Biology of The Interferon System, K Cantell, H Schellekens. Martinus Nijhoff Publishers, Dordrecht 1986; 435–441, In
   Google Scholar
• Kalo-Klein A, Witkin SS. Regulation of the immune response to Candida albicans monocytes and progesterone. Am J Obstet Gynecol 1991; 164: 1351–1354
   PubMed Web of Science ®Google Scholar
• Stobo JD, Paul S, Van Scoy RE, Hermans PE. Suppressor thymus-derived lymphocytes in fungal infection. J Clin Invest 1976; 57: 319–328
   PubMed Web of Science ®Google Scholar
• Piccolella E, Lombardi G, Morelli R. Generation of suppressor cells in the response of human lymphocytes to a polysaccharide from Candida albicans. J Immunol 1981; 126: 2151–2155
   PubMed Web of Science ®Google Scholar
• Podzorski RP, Gray GR, Nelson RD. Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro. J Immunol 1990; 144: 707–716
   PubMed Web of Science ®Google Scholar
• Poulain D. Candida and candidosis: the mannose interface. Abstracts of the 8th International Congress of Bacteriology and Applied Microbiology Division, JerusalemIsrael, August, 18–231996, abstract 132
   Google Scholar
• Cutler JE. Putative virulence factors of Candida albicans. Annu Rev Microbiol 1991; 45: 187–218
   PubMed Web of Science ®Google Scholar
• Wu T, Samaranayake LP, Cao BY, Wang J. In-vitro proteinase production by oral Candida albicans isolates from individuals with and without HIV infection and its attenuation by antimycotic agents. J Med Microbiol 1996; 44: 311–316
   PubMed Web of Science ®Google Scholar
• De Bernardis, F, Chiani, P, Ciccozzi, M, et al. Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with humanimmunodeficiency virus. Infect Immun 1996; 64: 466–471
   PubMed Web of Science ®Google Scholar
• McCullough M, Ross B, Reade PC. Oral Candida albicans from patients infected with the human immunodeficiency virus and characterization of a genetically distinct subgroup of Candida albicans. Austr Dent J 1995; 40: 91–97
   PubMed Web of Science ®Google Scholar